| Literature DB >> 26858982 |
Surleen Kaur1, G Anjali1, Priya Bhardwaj1, Jyoti Taneja1, Rita Singh1.
Abstract
Insulin receptor substrate-2 (IRS-2) plays critical role in the regulation of various metabolic processes by insulin and IGF-1. The defects in its expression and/or function are linked to diseases like polycystic ovary syndrome (PCOS), insulin resistance and cancer. To predict the transcription factors (TFs) responsible for the regulation of human IRS-2 gene expression, the transcription factor binding sites (TFBS) and the corresponding TFs were investigated by analysis of IRS-2 promoter sequence using MatInspector Genomatix software (Cartharius et al., 2005 [1]). The ibid data is part of author׳s publication (Anjali et al., 2015 [2]) that explains Follicle stimulating hormone (FSH) mediated IRS-2 promoter activation in human granulosa cells and its importance in the pathophysiology of PCOS. Further analysis was carried out for binary interactions of TF regulatory genes in IRS-2 network using Cytoscape software tool and R-code. In this manuscript, we describe the methodology used for the identification of TFBSs in human IRS-2 promoter region and provide details on experimental procedures, analysis method, validation of data and also the raw files. The purpose of this article is to provide the data on all TFBSs in the promoter region of human IRS-2 gene as it has the potential for prediction of the regulation of IRS-2 gene in normal or diseased cells from patients with metabolic disorders and cancer.Entities:
Keywords: ChIP; FSH; IRS-2; SP1; TFBS
Year: 2015 PMID: 26858982 PMCID: PMC4706562 DOI: 10.1016/j.dib.2015.12.001
Source DB: PubMed Journal: Data Brief ISSN: 2352-3409
Fig. 1Identification of putative transcription factor-binding sites in the IRS-2 promoter region using Genomatix MatInspector software.
Putative transcription factor binding sites in IRS-2 promoter region with match ≥15.
| ZF02 | Zinc finger with KRAB and SCAN domains 3 | 88 |
| ZF5F | Zinc finger/POZ domain transcription factor | 73 |
| KLFS | Kruppel-like factor 7 (ubiquitous, UKLF) | 70 |
| E2FF | E2F transcription factor 1 | 69 |
| PLAG | Pleomorphic adenoma gene | 56 |
| MZF1 | Myeloid zinc finger protein MZF1 | 50 |
| TF2B | Transcription factor II B (TFIIB) recognition element | 48 |
| IKZF | IKAROS family zinc finger 5 (Pegasus) | 44 |
| SP1F | Specificity protein 1, ubiquitous zinc finger transcription factor | 40 |
| EGRF | EGR1, early growth response 1 | 39 |
| SPZ1 | Spermatogenic Zip 1 transcription factor | 32 |
| EBOX | E-box binding factors | 29 |
| AP2F | Transcription factor AP-2, alpha | 28 |
| MAZF | Myc associated zinc fingers | 27 |
| IKRS | Ikaros 2, potential regulator of lymphocyte differentiation | 25 |
| HESF | Drosophila hairy and enhancer of split homolog 1 (HES-1) | 24 |
| NDPK | Nucleoside diphosphate kinase | 16 |
| AP1R | Transcription factor AP-1 | 15 |
Highlighted in yellow are the transcription factors activated by FSH.
SP1 binding sites identified in the human IRS-2 promoter region.
| SP1 | −50 | −66 | −58 | (−) | 1.000 | 0.912 | agcatGGGCggcgagcc |
| SP1 | −76 | −92 | −84 | (−) | 1.000 | 0.877 | ggcggGGGCtgcggcct |
| SP1 | −102 | −118 | −110 | (−) | 1.000 | 0.997 | gggcgGGGCgggggatc |
| SP1 | −107 | −123 | −115 | (−) | 1.000 | 0.968 | cggctGGGCggggcggg |
| SP1 | −118 | −134 | −126 | (−) | 1.000 | 0.873 | gggcgGGGCcgcggctg |
| SP1 | −123 | −139 | −131 | (−) | 1.000 | 0.966 | gcgccGGGCggggccgc |
| SP1 | −207 | −223 | −215 | (−) | 1.000 | 0.980 | gggcgGGGCgggccacg |
| SP1 | −212 | −228 | −220 | (−) | 1.000 | 0.990 | aagagGGGCggggcggg |
| SP1 | −237 | −253 | −245 | (−) | 1.000 | 0.924 | acccaGGGCgggaaaag |
| SP1 | −298 | −314 | −306 | (+) | 1.000 | 0.855 | ggccgGGGCcgccccac |
| SP1 | −300 | −316 | −308 | (−) | 1.000 | 0.926 | gggtgGGGCggccccgg |
| SP1 | −310 | −326 | −318 | (−) | 1.000 | 0.950 | cggccGGGCggggtggg |
| SP1 | −321 | −337 | −329 | (+) | 1.000 | 0.888 | cggccGGGCcggggcct |
| SP1 | −382 | −398 | −390 | (+) | 1.000 | 1.000 | aagggGGGCggggcggg |
| SP1 | −387 | −403 | −395 | (+) | 1.000 | 0.997 | gggcgGGGCgggggcgc |
| SP1 | −399 | −415 | −407 | (−) | 1.000 | 0.856 | ggggcGGGCcgcgcgcc |
| SP1 | −403 | −419 | −411 | (−) | 1.000 | 0.980 | cgcggGGGCgggccgcg |
| SP1 | −479 | −495 | −487 | (+) | 1.000 | 1.000 | cagcgGGGCggggcggc |
| SP1 | −484 | −500 | −492 | (+) | 1.000 | 0.919 | gggcgGGGCggccgcgc |
| SP1 | −753 | −769 | −761 | (−) | 1.000 | 0.887 | ccgcgGGGCcgagccta |
| SP1 | −782 | −798 | −790 | (−) | 1.000 | 0.886 | tcgctGGGCcgggagtc |
| SP1 | −808 | −824 | −816 | (−) | 1.000 | 0.921 | ctctcGGGCggcgccgg |
| SP1 | −864 | −880 | −872 | (−) | 1.000 | 0.920 | ggcgcGGGCggtggccg |
| SP1 | −987 | −1003 | −995 | (+) | 1.000 | 0.927 | tgatcGGGCgggcggcc |
| SP1 | −991 | −1007 | −999 | (+) | 1.000 | 0.894 | cgggcGGGCggccgggc |
| SP1 | −1025 | −1041 | −1033 | (−) | 1.000 | 0.963 | ggcgcGGGCgggggcgg |
| SP1 | −1040 | −1056 | −1048 | (−) | 1.000 | 0.944 | gcgagGGGCggaggggg |
Start/end position, starting/ending position of the consensus binding site in the sequence (relative to IRS-2); core similarity, core consensus sequence (4 highest conserved positions) similarity factor (0–1); matrix similarity; matrix (groups of functionally similar transcription factors) similarity factor (0–1); SP1/GC, stimulating protein 1/GC box elements.
Fig. 2FSH increases SP1 binding to IRS-2 promoter in human granulosa cells. ChIP assay was performed for verification of SP1 binding to IRS-2 promoter. Input reflects the relative amounts of sonicated DNA fragments before immunoprecipitations. (A) The relative amounts of IRS-2 promoter DNA fragments were determined with semi-quantitative PCR by separating the amplified product on 1.5% agarose gel. (B) The relative amounts of IRS-2 promoter DNA fragments were determined with qRT-PCR. Data are expressed as % input after normalizing the Ct values obtained from SP1 antibody treated samples with the Ct values from input DNA. Values presented are mean±SD from 3 independent experiments (n=3). *P<0.05 vs. untreated. − IgG as negative control; + SP1 Antibody; i Input (Total sonicated DNA) as positive control.
Fig. 3TF regulatory gene network for IRS-2.
| Subject area | |
|---|---|
| More specific subject area | |
| Type of data | |
| How data was acquired | |
| Data format | |
| Experimental factors | |
| Experimental features | |
| Data source location | |
| Data accessibility |